Sara Blumenstein
3Patents
2h-index
5Co-inventors
37Inventor score
Filing activity: Mar 21, 2002 → Feb 23, 2015
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8962556B2 | FGF-2 variants having N-terminal deletions and increased receptor selectivity and uses thereof | Human Necessities | 14 | Active |
| US8043807B2 | Methods and kits for determining a risk to develop cancer, for evaluating an effectiveness and dosage of cancer therapy and for correlating between an activity of a DNA repair enzyme and a cancer | Physics | 2 | Expired |
| US9862753B2 | FGF-2 variants having N-terminal deletions and increased receptor selectivity and methods of use thereof | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.